LMR Partners’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

LMR Partners’s Portfolio CMRAW Stock Details CMRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$300	–	1410
2023 Q4	$300	Hold	100,000	–	–	﹤0.01%	966
2023 Q3	$2.17K	Hold	100,000	–	–	﹤0.01%	898
2023 Q2	$2.71K	Hold	100,000	–	–	﹤0.01%	845
2023 Q1	$89.9K	Hold	100,000	–	–	﹤0.01%	950
2022 Q4	$123K	Hold	100,000	–	–	﹤0.01%	1029
2022 Q3	$161K	Hold	100,000	–	–	﹤0.01%	1030
2022 Q2	$264K	Buy	+100,000	New	+$16.4K	﹤0.01%	1025

LMR Partners's CMRAW Position: Q1 2024 in Review

LMR Partners sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q1 2024, closing a stake of 100,000 shares — an estimated $300 sold.

LMR Partners first reported a position in CMRAW in Q2 2022 and held it in 7 quarters. The position peaked at $264K in Q2 2022. 0 funds tracked by Wall St. Rank hold CMRAW as of Q1 2024.

LMR Partners reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 100,000 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q1 2024, an estimated $300.
LMR Partners first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 7 quarters.
LMR Partners's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $264K in Q2 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.